Hodpro 50 Capsule (Procarbazine 50mg)

Hodpro 50 Capsule

Hodpro 50Mg Capsule is a medication is primarily used to treat Hodgkin’s diseases (lymphadenoma). This is also used in the treatment of non-Hodgkin’s lymphoma, brain tumor, and bronchogenic carcinoma. It works by restricting the synthesis of protein, DNA and RNA which in turn stops or slows down the growth of cancer cells.

You should not use this medication if:

you have an allergy to it or any ingredient in the medicine
you have low platelets, anemia or reduced bone marrow function
you are suffering from chickenpox, shingles, liver problems or are on tricyclic antidepressants or sympathomimetic
you are pregnant, planning on becoming pregnant or breastfeeding
you are on any medications, or have or had any serious medical condition or infection
This medication is available only as capsules of strength 50mg to be taken by mouth. Its dosage varies depending on several factors like your height, weight, age, and medical conditions. Therefore it is advised that you consult a doctor and follow the dosage prescribed by him.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Use

The medication is helpful in treating the given problems:

Hodgkin’S Disease

Non-Hodgkin Lymphoma (Nhl)

Brain Tumor

Side Effects

A patient can suffer from the following side effects:

Nausea

Vomiting

Decreased Appetite

Stomatitis (Inflammation Of The Mouth)

Diarrhoea

Insomnia

Abdominal Pain

Anorexia

Peripheral Neuropathy

Dosage

Are there any overdose instructions?

Seek emergency medical treatment or contact the doctor in case of an overdose.
Are there any missed dose instructions?

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Work

This medication lowers the blood glucose within patients. It directly stimulates the release of insulin from the functioning of beta cells of the pancreatic islet tissue. It involves a method comprising sulfonylurea receptor acting on beta cell.